In early 2026, amid ongoing buzz for the One Chicago franchise—including the March 4 crossover “Reckoning”—old rumors about Torrey DeVitto’s departure from Chicago Med have resurfaced on fan forums and social media. Posts speculate that Dr. Natalie Manning “walked away” due to a “toxic set” environment, labeling her 2021 exit as the result of “behind-the-scenes hell.” However, interviews, production reports, and DeVitto’s own statements paint a different picture: a mutual, professional decision tied to contract expiration, creative dissatisfaction, and personal priorities rather than any documented toxicity.
DeVitto joined Chicago Med as Dr. Natalie Manning in the 2015 series premiere, becoming one of the original leads. Natalie, an ED pediatrician and widow, navigated complex storylines involving romance (notably with Nick Gehlfuss’s Dr. Will Halstead), ethical dilemmas, and family crises. Her arc peaked in Season 6 with a controversial decision to steal an experimental drug for her mother’s heart condition, leading to her firing by Sharon Goodwin (S. Epatha Merkerson) in the finale. Season 7 opened with Natalie relocating to Seattle, marking her scripted exit.
The real-world reason aligned closely with on-screen events. In a July 2024 appearance on Rachel Bilson’s Broad Ideas podcast, DeVitto explained that her contract ended after Season 6—a standard six-year network term—and the show chose not to renew it. She described the writers having “written my character in a really weird way and wrote her into a big hole that she could not get out of,” calling it “very bizarre.” DeVitto noted a “mutual conversation” about the change-up, adding she was “so grateful” because the consistent paycheck might have kept her from leaving otherwise. She emphasized wanting to focus on personal life and new opportunities, including the indie film Skelly.
No credible sources indicate a toxic environment driving her out. Searches for related drama yield no reports of conflicts, complaints, or investigations involving DeVitto on set. Past One Chicago controversies—like Jason Beghe’s 2017 reprimand on Chicago P.D.—did not extend to Chicago Med. DeVitto has spoken warmly about her castmates, calling them a loving group after six years together. In 2023 and 2025 interviews with NBC Insider, she described returns as “no-brainers” to support storylines, including Natalie’s Season 8 cameo reuniting with Will and a Season 11 appearance tied to ongoing arcs. She expressed love for the ensemble and openness to future cameos for a “happily ever after” payoff.
Rumors of “toxic set” likely stem from broader franchise patterns: repetitive storylines frustrating actors (Natalie’s love triangle loops), budget pressures leading to exits, and fan speculation amplifying departures. Similar claims have dogged other One Chicago stars, but DeVitto’s case remains clean—professional, amicable, and forward-looking. She has since pursued varied roles, guest spots, and personal projects without airing grievances.
As Chicago Med Season 11 progresses post-crossover—focusing on hospital crises, character evolutions, and cross-franchise ties—Natalie’s legacy endures through occasional returns. The “behind-the-scenes hell” narrative appears unsubstantiated, more a product of clickbait and nostalgia than reality. DeVitto walked away on good terms, ready for new chapters, leaving fans appreciative of her contributions to Gaffney Chicago Medical Center.